Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Helqvist

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Allergy|July 1, 1986
Chemotactic activity of LTB4 in manH Bisgaard, S Helqvist, L Boudet, et al.
Diabetes Care|November 1, 1988
Mechanisms of pancreatic beta-cell destruction in type I diabetesJ Nerup, T Mandrup-Poulsen, J Mølvig, et al.
Ugeskrift for Laeger|September 15, 1999
[Secondary prevention of ischemic heart disease. A questionnaire study and suggestions to improved cooperation between hospitals and general practice]J Bech, S Helqvist, H Hansen, et al.
Acta Endocrinologica|July 1, 1989
Interleukin 1 induces new protein formation in isolated rat islets of LangerhansS Helqvist, B Sehested Hansen, J Johannesen, et al.
Autoimmunity|January 1, 1990
Intra-peritoneal administration of interleukin-1 beta induces impaired insulin release from the perfused rat pancreasL Wogensen, S Helqvist, F Pociot, et al.
Heart (British Cardiac Society)|June 16, 2006
Percutaneous treatment of coronary bifurcation lesions: a novel "extended Y" technique with complete lesion stent coverageS Helqvist, E Jørgensen, H Kelbaek, et al.
Diabetes|February 1, 1990
Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial GroupT Mandrup-Poulsen, J Mølvig, H U Andersen, et al.
Current Topics in Microbiology and Immunology|January 1, 1990
Cytokine and free radicals as effector molecules in the destruction of pancreatic beta cellsT Mandrup-Poulsen, S Helqvist, L D Wogensen, et al.
Autoimmunity|January 1, 1991
Repetitive exposure of pancreatic islets to interleukin-1 beta. An in vitro model of pre-diabetes?S Helqvist, U W Zumsteg, G A Spinas, et al.
Diabetes|October 1, 1989
Interaction of beta-cell activity and IL-1 concentration and exposure time in isolated rat islets of LangerhansJ P Palmer, S Helqvist, G A Spinas, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Allergy|July 1, 1986
Chemotactic activity of LTB4 in manH Bisgaard, S Helqvist, L Boudet, et al.
Diabetes Care|November 1, 1988
Mechanisms of pancreatic beta-cell destruction in type I diabetesJ Nerup, T Mandrup-Poulsen, J Mølvig, et al.
Ugeskrift for Laeger|September 15, 1999
[Secondary prevention of ischemic heart disease. A questionnaire study and suggestions to improved cooperation between hospitals and general practice]J Bech, S Helqvist, H Hansen, et al.
Acta Endocrinologica|July 1, 1989
Interleukin 1 induces new protein formation in isolated rat islets of LangerhansS Helqvist, B Sehested Hansen, J Johannesen, et al.
Autoimmunity|January 1, 1990
Intra-peritoneal administration of interleukin-1 beta induces impaired insulin release from the perfused rat pancreasL Wogensen, S Helqvist, F Pociot, et al.
Heart (British Cardiac Society)|June 16, 2006
Percutaneous treatment of coronary bifurcation lesions: a novel "extended Y" technique with complete lesion stent coverageS Helqvist, E Jørgensen, H Kelbaek, et al.
Diabetes|February 1, 1990
Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial GroupT Mandrup-Poulsen, J Mølvig, H U Andersen, et al.
Current Topics in Microbiology and Immunology|January 1, 1990
Cytokine and free radicals as effector molecules in the destruction of pancreatic beta cellsT Mandrup-Poulsen, S Helqvist, L D Wogensen, et al.
Autoimmunity|January 1, 1991
Repetitive exposure of pancreatic islets to interleukin-1 beta. An in vitro model of pre-diabetes?S Helqvist, U W Zumsteg, G A Spinas, et al.
Diabetes|October 1, 1989
Interaction of beta-cell activity and IL-1 concentration and exposure time in isolated rat islets of LangerhansJ P Palmer, S Helqvist, G A Spinas, et al.
Pageof 3